These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 19553005)

  • 41. 17-Allylamino-17-Demethoxygeldanamycin and the Enhancement of PS-341-Induced Lung Cancer Cell Death by Blocking the NF-κB and PI3K/Akt Pathways.
    Lee KH; Jang AH; Yoo CG
    Am J Respir Cell Mol Biol; 2015 Sep; 53(3):412-21. PubMed ID: 25633180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling.
    Yang Y; Ikezoe T; Saito T; Kobayashi M; Koeffler HP; Taguchi H
    Cancer Sci; 2004 Feb; 95(2):176-80. PubMed ID: 14965369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC.
    Ryan SL; Beard S; Barr MP; Umezawa K; Heavey S; Godwin P; Gray SG; Cormican D; Finn SP; Gately KA; Davies AM; Thompson EW; Richard DJ; O'Byrne KJ; Adams MN; Baird AM
    Lung Cancer; 2019 Sep; 135():217-227. PubMed ID: 31446998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
    Xu CL; Lu XL; Yan XN; Wang HL; Chen SQ
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):134-8. PubMed ID: 22455747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro.
    Xiao P; Sun LL; Wang J; Han RL; Ma Q; Zhong DS
    Acta Pharmacol Sin; 2015 Sep; 36(9):1107-12. PubMed ID: 26027660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways.
    Huang CY; Fong YC; Lee CY; Chen MY; Tsai HC; Hsu HC; Tang CH
    Biochem Pharmacol; 2009 Mar; 77(5):794-803. PubMed ID: 19073147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sensitivity of two cell lines with acquired resistance to gefitinib to several chemotherapeutic drugs].
    Deng QF; Su B; Zhao YM; Zhou CC
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):813-6. PubMed ID: 19173824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
    Hu Y; Zang J; Cao H; Wu Y; Yan D; Qin X; Zhou L; Fan F; Ni J; Xu X; Sha H; Liu S; Yu S; Wang Z; Ma R; Wu J; Feng J
    Oncotarget; 2017 Feb; 8(9):15802-15814. PubMed ID: 28178657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.
    Yu M; Qi B; Xiaoxiang W; Xu J; Liu X
    Biomed Pharmacother; 2017 Jun; 90():677-685. PubMed ID: 28415048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
    Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
    Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.
    Brognard J; Clark AS; Ni Y; Dennis PA
    Cancer Res; 2001 May; 61(10):3986-97. PubMed ID: 11358816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells.
    Saitoh Y; Martínez Bruyn VJ; Uota S; Hasegawa A; Yamamoto N; Imoto I; Inazawa J; Yamaoka S
    Lung Cancer; 2010 Dec; 70(3):263-70. PubMed ID: 20338663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination of PTEN and gamma-ionizing radiation enhances cell death and G(2)/M arrest through regulation of AKT activity and p21 induction in non-small-cell lung cancer cells.
    Park JK; Jung HY; Park SH; Kang SY; Yi MR; Um HD; Hong SH
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1552-60. PubMed ID: 18374229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetochore scaffold 1 downregulation suppressed the development of non-small cell lung cancer by inactivating the phosphatidylinositol 3 kinase/protein kinase B (AKT)/nuclear factor-kappa B pathway.
    Wu L; Zhang G; Zhu Q; Huang Y
    J Physiol Pharmacol; 2024 Feb; 75(1):. PubMed ID: 38583438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
    Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.
    Rundall BK; Denlinger CE; Jones DR
    Surgery; 2004 Aug; 136(2):416-25. PubMed ID: 15300209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway.
    Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E
    Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
    Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.